GlassScriptPhysician profile
Mary Beth Luttrell
NPI 1487096665
$9,180.74
in general payments reported to CMS, 2019-2025
37 companies · $1,482 in 2025
The $1,482 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,639 · 2022: $1,653 · 2023: $2,357 · 2024: $2,051 · 2025: $1,482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,830 · Gift: $59.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,829.90 |
| Gift | $59.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,880.24 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,098.84 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Mannkind Corporation | $849.11 | 2021-2025 | Afrezza |
| Abbvie INC. | $805.65 | 2021-2025 | |
| Abbott Laboratories | $680.25 | 2021-2025 | Freestyle Libre 3, Octrode |
| Bayer Healthcare Pharmaceuticals INC. | $424.68 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $390.34 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Xeris Pharmaceuticals, INC. | $347.41 | 2021-2023 | Gvoke Hypopen |
| Amgen INC. | $284.70 | 2021-2024 | Evenity, Prolia, Repatha |
| Sanofi-Aventis U.S. LLC | $271.67 | 2021-2024 | |
| Corcept Therapeutics | $265.44 | 2022-2025 | Korlym |
| Boehringer Ingelheim Pharmaceuticals, INC. | $210.36 | 2021-2025 | Jardiance, Ofev |
| Zealand Pharma US, INC. | $195.39 | 2021-2022 | |
| Glaxosmithkline, LLC. | $173.37 | 2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Novartis Pharmaceuticals Corporation | $166.33 | 2021-2024 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $122.26 | 2021-2024 | Tymlos |
| Dexcom, INC. | $119.25 | 2021-2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $96.85 | 2024-2025 | |
| Tandem Diabetes Care, INC. | $80.29 | 2023-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Ardelyx, INC. | $73.88 | 2025 | Ibsrela |
| Cequr Corporation | $63.99 | 2022-2024 | Cequr Simplicity |
| Verona Pharma, INC. | $60.74 | 2025 | Ohtuvayre |
| Otsuka America Pharmaceutical, INC. | $56.83 | 2025 | Rexulti |
| Alkermes, INC. | $56.82 | 2021-2023 | Lybalvi |
| Insulet Corporation | $56.30 | 2022-2023 | Omnipod |
| Spr Therapeutics, INC | $49.16 | 2025 | Sprint Pns System |
| Exact Sciences Corporation | $46.86 | 2025 | Cologuard Collection Kit |
| Horizon Therapeutics Plc | $46.76 | 2022 | |
| Ibsa Pharma INC. | $46.29 | 2022-2023 | Tirosint, Licart |
| Merck Sharp & Dohme LLC | $29.30 | 2021 | |
| Lundbeck LLC | $25.54 | 2025 | Rexulti |
| Axsome Therapeutics, INC. | $25.13 | 2025 | Auvelity |
| Amarin Pharma, INC. | $22.69 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.10 | 2025 | Xifaxan |
| Alexion Pharmaceuticals, INC. | $15.78 | 2022 | |
| Alvogen INC | $14.71 | 2022 | |
| Beta Bionics, INC. | $11.43 | 2023 | Ilet Bionic Pancreas |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Beth Luttrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.